Product Information
AFREZZA (REGULAR INSULIN) 60-4 UNIT/60-8 UNIT/60-12 UNIT is a brand product labeled by Mannkind Corporation, priced at $10.3685 per EA under NDC 47918090218. Its NADAC has been published 176 times since Aug 21, 2019.
Manufacturer
Mannkind CorporationNDC
47918090218
Classification
Brand
Dosage Form
KIT
Route
RESPIRATORY (INHALATION)
Last Updated
4/1/2026
Approval Type
Biologic (BLA)
FDA Application
BLA022472On Market Since
1/10/2017
Price Statistics
The NADAC for AFREZZA (REGULAR INSULIN) 60-4 UNIT/60-8 UNIT/60-12 UNIT has been published 176 times since Aug 21, 2019, and over the history we have for it it has risen 49.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.3685 per EA |
|---|---|
| All-time high | $10.3685 (Jun 24, 2026) |
| All-time low | $6.9261 (Aug 21, 2019) |
| 52-week high | $10.3685 |
| 52-week low | $10.0714 |
| Median price | $9.6504 |
| Average price | $9.1226 |
| Largest weekly change | +27.6% (Apr 17, 2024) |
| Weeks tracked | 176 |
| Tracking since | Aug 21, 2019 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of AFREZZA (REGULAR INSULIN) 60-4 UNIT/60-8 UNIT/60-12 UNIT?
The current National Average Drug Acquisition Cost (NADAC) for AFREZZA (REGULAR INSULIN) 60-4 UNIT/60-8 UNIT/60-12 UNIT, manufactured by Mannkind Corporation, is $10.3685 per EA (NDC 47918090218), effective Jun 24, 2026.
How has the price of AFREZZA (REGULAR INSULIN) 60-4 UNIT/60-8 UNIT/60-12 UNIT changed over time?
Over the history we have for it, the NADAC for AFREZZA (REGULAR INSULIN) 60-4 UNIT/60-8 UNIT/60-12 UNIT has risen 49.7%. It has been tracked across 176 weekly CMS publications since Aug 21, 2019.
What are the highest and lowest recorded NADAC prices for AFREZZA (REGULAR INSULIN) 60-4 UNIT/60-8 UNIT/60-12 UNIT?
Since Aug 21, 2019, the NADAC for AFREZZA (REGULAR INSULIN) 60-4 UNIT/60-8 UNIT/60-12 UNIT has ranged from a low of $6.9261 (Aug 21, 2019) to a high of $10.3685 (Jun 24, 2026), with a median of $9.6504 per EA.
Are there cheaper alternatives to AFREZZA (REGULAR INSULIN) 60-4 UNIT/60-8 UNIT/60-12 UNIT?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, AFREZZA (REGULAR INSULIN) 90-4 UNIT / 90-8 UNIT, is $7.8585 per EA — about 24% below AFREZZA (REGULAR INSULIN) 60-4 UNIT/60-8 UNIT/60-12 UNIT.
Who manufactures AFREZZA (REGULAR INSULIN) 60-4 UNIT/60-8 UNIT/60-12 UNIT?
AFREZZA (REGULAR INSULIN) 60-4 UNIT/60-8 UNIT/60-12 UNIT (NDC 47918090218) is labeled by Mannkind Corporation, and CMS classifies it as a brand product.
Related Drugs
Same classification